Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers

NCT01347086 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Matching placebo (low dose)
DRUG: BI 207127 NA (medium dose)
DRUG: BI 207127 NA (low dose)
DRUG: Matching placebo (medium dose)
DRUG: BI 207127 NA (high dose)
DRUG: Matching placebo (high dose)

Sponsor

Boehringer Ingelheim